Impact of "day 90" CD4+ T cells on clinical outcomes in children with relapsed/refractory acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.
Jin YangQin LuWei JingJing LingBohan LiWei GaoShengqin ChengPeifang XiaoJie LiGuihua ShuJun LuShaoyan HuPublished in: Transplant immunology (2024)
CD4+ T cell count may be used to identify pediatric patients with R/R-AML with a greater mortality risk early after HSCT.